J Clin Neurol.  2017 Jan;13(1):62-70. 10.3988/jcn.2017.13.1.62.

SCN1A Gene Mutation and Adaptive Functioning in 18 Vietnamese Children with Dravet Syndrome

Affiliations
  • 1Research Center for Genetics and Reproductive Health, School of Medicine, Vietnam National University HCMC, Ho Chi Minh City, Vietnam. hangdo009@gmail.com
  • 2Center for Molecular Biomedicine, University of Medicine and Pharmacy HCMC, Ho Chi Minh City, Vietnam.
  • 3Neurology Department, Children Hospital 2, Ho Chi Minh City, Vietnam.
  • 4Department of Herbal Medicine Resource, Institute of Bioscience and Biotechnology, Kangwon National University, Samcheok, Korea.
  • 5Department of Laboratory Medicine, Faculty of Nursing and Medical Technology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
  • 6National Institute of Forensic Medicine, Hanoi, Vietnam.

Abstract

BACKGROUND AND PURPOSE
Dravet syndrome is a rare and severe type of epilepsy in infants. The heterogeneity in the overall intellectual disability that these patients suffer from has been attributed to differences in genetic background and epilepsy severity.
METHODS
Eighteen Vietnamese children diagnosed with Dravet syndrome were included in this study. SCN1A variants were screened by direct sequencing and multiplex ligation-dependent probe amplification. Adaptive functioning was assessed in all patients using the Vietnamese version of the Vineland Adaptive Behavior Scales, and the results were analyzed relative to the SCN1A variants and epilepsy severity.
RESULTS
We identified 13 pathogenic or likely pathogenic variants, including 6 that have not been reported previously. We found no correlations between the presence or type of SCN1A variants and the level of adaptive functioning impairment or severity of epilepsy. Only two of nine patients aged at least 5 years had an adaptive functioning score higher than 50. Both of these patients had a low frequency of convulsive seizures and no history of status epilepticus or prolonged seizures. The remaining seven had very low adaptive functioning scores (39 or less) despite the variability in the severity of their epilepsy confirming the involvement of factors other than the severity of epilepsy in determining the developmental outcome.
CONCLUSIONS
Our study expands the spectrum of known SCN1A variants and confirms the current understanding of the role of the genetic background and epilepsy severity in determining the developmental outcome of Dravet syndrome patients.

Keyword

dravet syndrome; Vietnamese; adaptive functioning; SCN1A

MeSH Terms

Adaptation, Psychological
Asian Continental Ancestry Group*
Child*
Epilepsies, Myoclonic*
Epilepsy
Genetic Background
Humans
Infant
Intellectual Disability
Multiplex Polymerase Chain Reaction
Population Characteristics
Seizures
Status Epilepticus
Weights and Measures

Figure

  • Fig. 1 Adaptive functioning as assessed using the Vietnamese version of the Vineland Adaptive Behavior Scales (VVABS) in all 18 included patients during their last visit.


Reference

1. Dravet C. The core Dravet syndrome phenotype. Epilepsia. 2011; 52:Suppl 2. 3–9.
Article
2. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001; 68:1327–1332.
Article
3. Scheffer IE. Diagnosis and long-term course of Dravet syndrome. Eur J Paediatr Neurol. 2012; 16:Suppl 1. S5–S8.
Article
4. Carvill GL, Weckhuysen S, McMahon JM, Hartmann C, Møller RS, Hjalgrim H, et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology. 2014; 82:1245–1253.
Article
5. Suls A, Jaehn JA, Kecskés A, Weber Y, Weckhuysen S, Craiu DC, et al. De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome. Am J Hum Genet. 2013; 93:967–975.
Article
6. Parihar R, Ganesh S. The SCN1A gene variants and epileptic encephalopathies. J Hum Genet. 2013; 58:573–580.
Article
7. Lim BC, Hwang H, Chae JH, Choi JE, Hwang YS, Kang SH, et al. SCN1A mutational analysis in Korean patients with Dravet syndrome. Seizure. 2011; 20:789–794.
Article
8. Kwong AK, Fung CW, Chan SY, Wong VC. Identification of SCN1A and PCDH19 mutations in Chinese children with Dravet syndrome. PLoS One. 2012; 7:e41802.
Article
9. Chieffo D, Battaglia D, Lettori D, Del Re M, Brogna C, Dravet C, et al. Neuropsychological development in children with Dravet syndrome. Epilepsy Res. 2011; 95:86–93.
Article
10. Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM, et al. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain. 2012; 135(Pt 8):2329–2336.
Article
11. Ragona F, Granata T, Dalla Bernardina B, Offredi F, Darra F, Battaglia D, et al. Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients. Epilepsia. 2011; 52:386–392.
Article
12. Brunklaus A, Zuberi SM. Dravet syndrome--from epileptic encephalopathy to channelopathy. Epilepsia. 2014; 55:979–984.
Article
13. Guerrini R, Oguni H. Borderline Dravet syndrome: a useful diagnostic category? Epilepsia. 2011; 52:Suppl 2. 10–12.
Article
14. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17:405–424.
Article
15. Goldberg MR, Dill CA, Shin JY, Nguyen VN. Reliability and validity of the Vietnamese Vineland Adaptive Behavior Scales with preschool-age children. Res Dev Disabil. 2009; 30:592–602.
Article
16. Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet. 2009; 46:183–191.
Article
17. Oguni H, Hayashi K, Awaya Y, Fukuyama Y, Osawa M. Severe myoclonic epilepsy in infants--a review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev. 2001; 23:736–748.
Article
18. Kobayashi K, Ohmori I, Ouchida M, Ohtsuka Y. Dravet syndrome with an exceptionally good seizure outcome in two adolescents. Epileptic Disord. 2011; 13:340–344.
Article
19. Akiyama M, Kobayashi K, Yoshinaga H, Ohtsuka Y. A long-term follow-up study of Dravet syndrome up to adulthood. Epilepsia. 2010; 51:1043–1052.
Article
20. Kanai K, Hirose S, Oguni H, Fukuma G, Shirasaka Y, Miyajima T, et al. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity. Neurology. 2004; 63:329–334.
Article
21. Zuberi SM, Brunklaus A, Birch R, Reavey E, Duncan J, Forbes GH. Genotype-phenotype associations in SCN1A-related epilepsies. Neurology. 2011; 76:594–600.
Article
22. Marini C, Mei D, Temudo T, Ferrari AR, Buti D, Dravet C, et al. Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia. 2007; 48:1678–1685.
Article
23. Wolff M, Cassé-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia. 2006; 47:Suppl 2. 45–48.
Article
24. Ragona F, Brazzo D, De Giorgi I, Morbi M, Freri E, Teutonico F, et al. Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients. Brain Dev. 2010; 32:71–77.
Article
25. Villeneuve N, Laguitton V, Viellard M, Lépine A, Chabrol B, Dravet C, et al. Cognitive and adaptive evaluation of 21 consecutive patients with Dravet syndrome. Epilepsy Behav. 2014; 31:143–148.
Article
26. Yu MJ, Shi YW, Gao MM, Deng WY, Liu XR, Chen L, et al. Milder phenotype with SCN1A truncation mutation other than SMEI. Seizure. 2010; 19:443–445.
Article
27. Gennaro E, Veggiotti P, Malacarne M, Madia F, Cecconi M, Cardinali S, et al. Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. Epileptic Disord. 2003; 5:21–25.
28. Dravet C. How Dravet syndrome became a model for studying childhood genetic epilepsies. Brain. 2012; 135(Pt 8):2309–2311.
Article
29. Catarino CB, Liu JY, Liagkouras I, Gibbons VS, Labrum RW, Ellis R, et al. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain. 2011; 134(Pt 10):2982–3010.
Article
30. Bender AC, Natola H, Ndong C, Holmes GL, Scott RC, Lenck-Santini PP. Focal Scn1a knockdown induces cognitive impairment without seizures. Neurobiol Dis. 2013; 54:297–307.
Article
31. Nabbout R, Chemaly N, Chipaux M, Barcia G, Bouis C, Dubouch C, et al. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy. Orphanet J Rare Dis. 2013; 8:176.
Article
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr